BioXcel Therapeutics (BTAI) Interest Expenses (2017 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Interest Expenses of $4.2 million for Q1 2026, up 5.13% year-over-year from $4.0 million in Q1 2025, and up 244.86% quarter-over-quarter from -$2.9 million in Q4 2025.
BioXcel Therapeutics (BTAI) Interest Expenses (2017 - 2026) Analysis & Trends
BioXcel Therapeutics' Interest Expenses history runs 10 years deep, the most recent figure standing at $4.2 million for Q1 2026.
- In Q1 2026, Interest Expenses rose 5.13% year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at $9.5 million (up 9.94% YoY), while the FY2025 annual figure was $17.0 million, down 91.16% from the prior year.
- Interest Expenses for Q1 2026 stood at $4.2 million, up from -$2.9 million in the prior quarter.
- The five-year high for Interest Expenses was $118.4 million in Q4 2022, with the low at -$2.9 million in Q4 2025.
- The 5-year median for Interest Expenses is $4.2 million (2026), against an average of $16.8 million.
- The sharpest annual moves came in 2022 and 2024: Interest Expenses jumped 1972783.33% in 2022, then sank 239.86% in 2024.
- BioXcel Therapeutics' Interest Expenses stood at $118.4 million in 2022, then sank by 98.26% to $2.1 million in 2023, then tumbled by 239.86% to -$2.9 million in 2024, then retreated by 0.49% to -$2.9 million in 2025, then surged by 244.86% to $4.2 million in 2026.
- Business Quant data shows BTAI's Interest Expenses at $4.2 million in Q1 2026, -$2.9 million in Q4 2025, and $3.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | BioXcel Therapeutics | 24.73 Mn | 24.73 Mn | 160,000.00 | 4.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.26 Mn |
| Jun 30, 2026 | 4.26 Mn |
| Mar 31, 2026 | 4.20 Mn |
| Mar 31, 2026 | 4.20 Mn |
| Dec 31, 2025 | -2.90 Mn |
| Dec 31, 2025 | -2.90 Mn |
| Sep 30, 2025 | 3.93 Mn |
| Sep 30, 2025 | 3.93 Mn |
| Jun 30, 2025 | 4.22 Mn |
| Jun 30, 2025 | 4.22 Mn |
| Mar 31, 2025 | 3.99 Mn |
| Mar 31, 2025 | 3.99 Mn |
| Dec 31, 2024 | -2.88 Mn |
| Dec 31, 2024 | -2.88 Mn |
| Sep 30, 2024 | 3.79 Mn |
| Sep 30, 2024 | 3.79 Mn |
| Jun 30, 2024 | 3.70 Mn |
| Jun 30, 2024 | 3.70 Mn |
| Mar 31, 2024 | 3.61 Mn |
| Mar 31, 2024 | 3.61 Mn |